These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2584341)

  • 1. Column liquid chromatography of calcium channel blockers.
    Waki H; Ando S
    J Chromatogr; 1989 Sep; 494():408-12. PubMed ID: 2584341
    [No Abstract]   [Full Text] [Related]  

  • 2. [High performance liquid chromatographic determination of flunarizine in biological materials].
    Kobayashi S; Takai K; Inoue A
    Yakugaku Zasshi; 1986 Mar; 106(3):217-20. PubMed ID: 3723345
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of the calcium antagonist flunarizine in biological fluids by gas-liquid chromatography.
    Flor SC
    J Chromatogr; 1983 Feb; 272(2):315-23. PubMed ID: 6833428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of flunarizine in rat brain by liquid chromatography-electrospray mass spectrometry.
    Fuh MR; Hsieh CJ
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):167-73. PubMed ID: 10676996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in the uptake of calcium channel blockers by brain capillary endothelial cells and synaptosomal fractions.
    Waki H; Kon K; Tanaka Y; Ando S
    Neurosci Lett; 1990 Aug; 116(3):367-71. PubMed ID: 2243616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of (trans)-1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride with HPLC].
    Ficarra P; Ficarra R; Tommasini A; Calabro ML
    Boll Chim Farm; 1985 Jan; 124(1):39-45. PubMed ID: 4015866
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidative metabolism of flunarizine in rat liver microsomes.
    Kariya S; Isozaki S; Narimatsu S; Suzuki T
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):85-95. PubMed ID: 1462051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine.
    Kariya S; Isozaki S; Masubuchi Y; Suzuki T; Narimatsu S
    Biochem Pharmacol; 1995 Nov; 50(10):1645-50. PubMed ID: 7503767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of a calcium antagonist (PU 122) in plasma by gas chromatography.
    Marzo A; Treffner E; Meroni G; Ripamonti M; Pelloso R; Lucarelli C
    J Chromatogr; 1989 Dec; 497():296-301. PubMed ID: 2625466
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the calcium channel blockers cinnarizine and flunarizine on gastric histamine content in rats with experimentally-induced ulcers.
    Belcheva A; Marazova K; Lozeva V
    Pharmazie; 1992 Jan; 47(1):65-6. PubMed ID: 1376930
    [No Abstract]   [Full Text] [Related]  

  • 11. [GABA reuptake by rat brain slices in hypokinesia and under the influence of cinnarizine and flunarizine].
    Mirzoian NR; Akopian VP; Kocharian AZh; Knarian VA; Arakelian LN; Gevorkian GA
    Eksp Klin Farmakol; 1998; 61(5):15-7. PubMed ID: 9854625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers in migraine.
    Solomon GD
    Lancet; 1982 Jul; 2(8290):162. PubMed ID: 6123877
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J; Borgers M; Van Dael L; Van Eyndhoven J; Van De Ven M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic studies with flunarizine, a calcium influx blocker.
    Gulati N; Huggel H; Gulati OP
    Arch Int Pharmacodyn Ther; 1983 May; 263(1):17-27. PubMed ID: 6615081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of flunarizine in the prophylaxis of migraine.
    Centonze V; Tesauro P; Trizio T; Magrone D; Vino M; Macinagrossa G; Campanozzi F; Altomare E; Attolini E; Albano O
    Cephalalgia; 1985 May; 5 Suppl 2():165-8. PubMed ID: 3893737
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
    Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL
    Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
    Wörz R; Drillisch C
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of the calcium channel blockers cinnarizine and flunarizine on the duration of hexobarbital-induced sleep i rats].
    Marazova KD; Lozeva VG; Belcheva-Beronova A
    Eksp Klin Farmakol; 1993; 56(2):16-8. PubMed ID: 8348027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem auditory evoked potentials in migraine patients in basal conditions and after chronic flunarizine treatment.
    Bussone G; Sinatra MG; Boiardi A; La Mantia L; Frediani F; Cocchini F
    Cephalalgia; 1985 May; 5 Suppl 2():177-80. PubMed ID: 4016931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.